Elsevier

Steroids

Volume 65, Issue 8, August 2000, Pages 423-427
Steroids

Rapid communication
Selective activation of liver X receptor alpha by 6α-hydroxy bile acids and analogs

https://doi.org/10.1016/S0039-128X(00)00127-6Get rights and content

Abstract

We have found that certain natural 6α-hydroxylated bile acids are receptor-specific activators of nuclear liver X receptor alpha (LXRα) (NR1H3), a nuclear receptor regulating the expression of the cholesterol 7α-hydroxylase gene, coding for the rate-limiting enzyme in the major pathway of bile acid synthesis. The LXR homolog, ubiquitous nuclear receptor (UR/LXRβ) (NR1H2), was also activated by these bile acids, but at higher concentrations than for LXRα. Synthetic 6α-hydroxylated bile acid analogs were synthesized with LXRα-selective agonistic activity, with potential to modulate cholesterol catabolism in hypercholesterolemia.

Introduction

Bile acids are synthesized from cholesterol by two pathways [1], [2]. The first is the classic or neutral pathway in which cholesterol 7α-hydroxylase catalyzes the first step. In the second, known as the acidic pathway, cholesterol is first oxidized to form 27-hydroxycholesterol and later by an oxysterol 7α-hydroxylase [3], [4]. Another alternative step involves 6-hydroxylation of primary or secondary bile acids. In the acidic pathway of bile acid synthesis, cholesterol is first hydroxylated and oxidized at the side chain C-27 position. The bile acids ultimately formed can then be hydroxylated at the 6α position by a cytochrome P450 enzyme coded by the CYP3A4 gene [5]. Natural 6α-hydroxylated steroids with 24-keto side chains include free and conjugated 3α, 6α-dihydroxy-5β-cholanoic (hyodeoxycholic) [6], [7] and 3α,6α,7α-trihydroxy-5β-cholanoic (hyocholic) acids [8].

Recently a role for certain nuclear receptors in cholesterol catabolism was defined [9], [10], [11], [12], [13], [14]. RLD-1/LXR (LXRα) [15], [16] was identified as a transcriptional activator of the cholesterol 7α-hydroxylase gene. Genetically engineered mice with a LXRα deficiency maintain basal expression of cholesterol 7α-hydroxylase, but fail to up regulate 7α-hydroxylase expression in response to a high-cholesterol diet [10]. The nuclear receptor UR/NER/OR-1/RIP15 (UR/LXRβ) [17], [18], [19], [20], which shares high structural homology and oxycholesterol ligand specificity with LXRα and is ubiquitously expressed, did not compensate for the loss of LXRα expression [10]. This paper describes selective activation of LXRα by 6α-hydroxy bile acids and their analogs.

Section snippets

Transactivation assay

Human embryonic kidney 293 cells were seeded into 48-well culture plates at 105 cells per well in DMEM supplemented with 10% fetal bovine serum. After 24 h, cells were transfected by a calcium phosphate coprecipitation method with 250 ng of the pGL3/UREluc reporter gene that consists of three copies of AGGTCAagccAGGTCA fused to nucleotides −56 to +109 of the human c-fos promoter in front of the firefly luciferase gene in the plasmid basic pGL3 (Promega, Madison, WI, USA), 40 ng pSG5/hRXRα, 40

Results

In this study, we co-transfected human embryonic kidney 293 cells with a LXRα/UR reporter vector (pGL3/UREluc), along with expression vectors for LXRα or UR, RXRα, and the co-activator Grip1. Test compounds were added to the culture media and reporter gene expression was measured. Using this assay system, we determined the ED50 for oxysterol ligands (e.g. 100 nM for N,N-dimethyl-3β-hydroxy-5-cholenamide, Fig. 2j) for both receptors and these values were in agreement with the published Ki of

Discussion

The acidic bile acid synthesis pathway has been proposed to have regulatory roles for cholesterol catabolism [28]. Based on the data presented here, it remains a possibility that 6α-hydroxy bile acids, products of the acidic bile acid pathway, which are normally not present in large quantity, but accumulate in 7α-hydroxylation blockage, are an endogenous signal serving as natural ligands for LXRα regulating expression of the cholesterol 7α-hydroxylase, the rate-limiting enzyme of the neutral

Acknowledgements

The authors would like to thank Dr J. Y. Chiang for the rat pGL2/7αluc reporter plasmid and human PH/hCYP7A-135 7α-hydroxylase reporter plasmids, Dr D. J. Mangelsdorf for CMV/hLXRα, Dr P. A. Dawson for pCMV/hIBAT, Dr M. Stallcup for pSG5/hGrip1, and Dr Fangjie Zhang for advice on chemical synthesis. This work was supported by NIH grants.

References (30)

Cited by (109)

  • Structures and functions of the gut microbial lipidome

    2022, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
  • The cross talk between bile acids and intestinal microbiota: Focus on metabolic diseases and bariatric surgery

    2019, Microbiome and Metabolome in Diagnosis, Therapy, and other Strategic Applications
View all citing articles on Scopus
View full text